The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Wieslaw M. Kazmierski

Infectious Diseases Center for Excellence in Drug Discovery

GlaxoSmithKline

Five Moore Drive

Research Triangle Park

USA

[email]@gsk.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Infectious Diseases Center for Excellence in Drug Discovery, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, USA. 2008
  • GlaxoSmithKline, Research Triangle Park, NC 27709, USA. 2002 - 2006
  • Division of Chemistry MV CEDD, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, USA. 2006

References

  1. Discovery of bioavailable 4,4-disubstituted piperidines as potent ligands of the chemokine receptor 5 and inhibitors of the human immunodeficiency virus-1. Kazmierski, W.M., Aquino, C., Chauder, B.A., Deanda, F., Ferris, R., Jones-Hertzog, D.K., Kenakin, T., Koble, C.S., Watson, C., Wheelan, P., Yang, H., Youngman, M. J. Med. Chem. (2008) [Pubmed]
  2. Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4. Kazmierski, W.M., Kenakin, T.P., Gudmundsson, K.S. Chemical. Biology. &. Drug. Design (2006) [Pubmed]
  3. New, potent P1/P2-morpholinone-based HIV-protease inhibitors. Kazmierski, W.M., Furfine, E., Spaltenstein, A., Wright, L.L. Bioorg. Med. Chem. Lett. (2006) [Pubmed]
  4. Potent inhibitors of the HIV-1 protease incorporating cyclic urea P1-P2 scaffold. Kazmierski, W.M., Furfine, E., Gray-Nunez, Y., Spaltenstein, A., Wright, L. Bioorg. Med. Chem. Lett. (2004) [Pubmed]
  5. Discovery of potent pyrrolidone-based HIV-1 protease inhibitors with enhanced drug-like properties. Kazmierski, W.M., Andrews, W., Furfine, E., Spaltenstein, A., Wright, L. Bioorg. Med. Chem. Lett. (2004) [Pubmed]
  6. Novel prodrug approach to amprenavir-based HIV-1 protease inhibitors via O-->N acyloxy migration of P1 moiety. Kazmierski, W.M., Bevans, P., Furfine, E., Spaltenstein, A., Yang, H. Bioorg. Med. Chem. Lett. (2003) [Pubmed]
  7. Novel spirocyclic pyrrolidones as P2/P1 mimetics in potent inhibitors of HIV-1 protease. Kazmierski, W.M., Furfine, E., Spaltenstein, A., Wright, L.L. Bioorg. Med. Chem. Lett. (2002) [Pubmed]
 
WikiGenes - Universities